(Q47849302)

6 February 2018

title

Expression of interferon regulatory factor 1, 3, and 7 in primary Sjögren syndrome. (English)

1 reference

6 February 2018

author name string

Lingyan Zheng

1

1 reference

6 February 2018

Chuangqi Yu

2

1 reference

6 February 2018

Zhiyuan Zhang

3

1 reference

6 February 2018

Chi Yang

4

1 reference

6 February 2018

Xieyi Cai

5

1 reference

6 February 2018

publication date

1 May 2009

1 reference

6 February 2018

Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontics

published in

1 reference

6 February 2018

volume

107

1 reference

6 February 2018

issue

5

1 reference

6 February 2018

page(s)

661-668

1 reference

6 February 2018

Sjögren's syndrome criteria

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Genetic aspects of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Immunopathogenesis of primary Sjögren's syndrome: implications for disease management and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Update in Sjögren syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

The possible etiopathogenic genes of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Hepatitis C virus and Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Viruses contribute to the development of Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Evidence for coxsackievirus infection in primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Activation of Epstein-Barr virus by saliva from Sjogren's syndrome patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Gene expression profiling of minor salivary glands clearly distinguishes primary Sjögren's syndrome patients from healthy control subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

TLR signalling and activation of IRFs: revisiting old friends from the NF-kappaB pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Type I interferon [corrected] gene induction by the interferon regulatory factor family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Interferon regulatory factors: the next generation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

The Th1/Th2 cytokine balance changes with the progress of the immunopathological lesion of Sjogren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Cytokine messenger RNA expression in the labial salivary glands of patients with Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Disproportion of helper T cell subsets in peripheral blood of patients with primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Activation of the type I interferon system in primary Sjögren's syndrome: a possible etiopathogenic mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Salivary proteomic and genomic biomarkers for primary Sjögren's syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRIPLEO.2009.01.039

10.1016/J.TRIPLEO.2009.01.039

7 January 2021

Identifiers

DOI

1 reference

6 February 2018

PubMed ID

19426920

1 reference

6 February 2018